draflazine has been researched along with Disease Models, Animal in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iimura, O; Itoya, M; Miura, T; Sakamoto, J; Urabe, K | 1 |
1 other study(ies) available for draflazine and Disease Models, Animal
| Article | Year |
|---|---|
Nucleoside transport inhibitors enhance the infarct size-limiting effect of ischemic preconditioning.
Topics: Animals; Blood Pressure; Dilazep; Disease Models, Animal; Epoprostenol; Heart Rate; Injections, Intravenous; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Nucleosides; Phosphoric Diester Hydrolases; Piperazines; Platelet Aggregation Inhibitors; Rabbits | 1994 |